Opinion | The Dangerous Double Standards of RFK Jr.'s Health Crusade
FDA scientists warn that some popular peptides are ineffective and potentially dangerous.
Opinion | RFK Jr.'s hypocritical quackery
Robert F. Kennedy Jr. has long positioned himself as a champion of health freedom and a crusader against what he calls the corruption of federal health agencies. Yet as he pushes to reshape the FDA and loosen regulations on supplements and alternative treatments, career scientists within the agency are sounding alarms about a category of products that Kennedy and his allies have enthusiastically promoted: synthetic peptides. These compounds, marketed online as miracle treatments for everything from aging to weight loss to cognitive enhancement, have become a booming and largely unregulated industry — one that FDA researchers say poses real risks to unsuspecting consumers.
FDA scientists have published warnings noting that many popular peptides sold through compounding pharmacies and online retailers have not undergone rigorous clinical testing. Compounds such as BPC-157, marketed as a healing agent for injuries and gut health, have shown some promise in animal studies but lack the human trial data necessary to establish safety or efficacy. Researchers caution that without proper oversight, consumers are essentially experimenting on themselves with substances whose long-term effects remain unknown, and whose purity and dosing cannot be guaranteed when purchased outside regulated channels.
The irony of Kennedy's position is difficult to ignore. The man who built his political brand on questioning the safety of FDA-approved vaccines — products that have undergone extensive clinical trials — now advocates for easier access to compounds that have undergone virtually none. His rhetoric about protecting Americans from untested pharmaceutical products rings hollow when he simultaneously champions the deregulation of substances that scientists say could cause hormone disruption, organ damage, and dangerous drug interactions. Critics argue this represents not principled skepticism of the medical establishment but a selective and commercially convenient philosophy.
Public health advocates worry that Kennedy's influence could create a dangerous regulatory vacuum at precisely the wrong moment. The peptide market is already estimated at billions of dollars annually, and loosening FDA enforcement would only accelerate its growth. Scientists urge that the answer is not to eliminate oversight but to fund proper research into these compounds so that consumers can make truly informed decisions. Without that commitment, they warn, the health freedom movement risks becoming little more than a permission slip for quackery dressed up in the language of personal choice.